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Background: The prevalence of asthma appears to be on the increase, and risk factors are not well established. 
To investigate risk factors for the development of asthma, a population sample of children and adolescents, 
aged 7-17 years at enrolment, were studied in 1986. Initial examinations were repeated at follow-up in 1992; 
complete data was available for 408 subjects (199 males). 
Methods: Obtained case histories were used to assess the presence of asthma; pulmonary function, skin prick 
test reactivity, total serum IgE and bronchial responsiveness to inhaled histamine were measured using 
standard techniques. 
Results: The 12-month period prevalence of asthma increased significantly from the first to the second 
examination in both males (P<O.OOl) and females (P~O.001): whereas the number of subjects with a positive 
histamine challenge test declined in both sexes, although this was only statistically significant in males 
(P<O.OOl). The prevalence of a positive skin prick test was higher at the second examination (26% and 44%, 
respectively, P<O.OOl); the proportion of subjects with a positive skin reaction to house dust mite (HDM pos) 
increased from 14% to 26%. Bronchial hyper-responsiveness to inhaled histamine (BHR), HDM allergy, a 
history of wheezy bronchitis and symptoms of asthma at first examination were more prevalent among 
subjects reporting asthma at the second examination than among subjects without respiratory symptoms. 
Confining the analysis to subjects without a history of asthma at the first examination showed that 
asymptomatic BHR {Odds ratio [OR] 3.8 [95% confidence interval (CI) 2.5-5.11, P=O.O002), HDM pos [OR 
2.6 (95% CI 1.9-3.3) P=O.OOS], a history of wheezy bronchitis before the age of 2 years [OR 3.8 (95% CI 
2.4-5.2), P=O.O06] and a history of rhinitis and/or eczema [OR 2.8 (95% CI 1.7-3.9), P=O.O07] at first 
examination were associated with an increased risk for development of symptomatic asthma at some point 
between the two examinations. No significant relationship could be demonstrated between smoking (passive 
or active) and the risk for development of asthmatic symptoms. 
Conclusions: In conclusion, this longitudinal population study showed an increase in the 12-month period 
prevalence of asthma with sensitization to HDM and asymptomatic BHR as important risk factors for 
development of asthma; the temporal relationship between sensitization to HDM and presence of airway 
abnormalities needs to be explored further. 
Introduction 
Recent studies suggest that the prevalence of 
asthma is rising in children and adolescents (1,2), 
regardless of whether assessment has been based on 
questionnaire data alone or in combination with a 
test of non-specific bronchial responsiveness (335). 
This increase in prevalence has been accompanied by 
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an increase in morbidity, as measured by proportion 
of children consulting their general practitioner, and 
hospital admissions from asthma (1,6,7). It is a 
matter of dispute whether this increase reflects 
changes in asthma epidemiology (true increase in 
incidence) and/or increasing severity of symptoms. 
Although a combination of artefacts and changes in 
medical care (earlier medical intervention and/or 
more focus on asthma) could be partially responsible, 
it has gained widespread acceptance that recognized 
asthma is on the increase. This has caused consider- 
able concern and pointed out the importance of 
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studies on factors predicting remission, persistence 
and, not least, development of symptomatic asthma 
in both children and adults. To study this, a longi- 
tudinal study looking at the presence of asthma, 
bronchial hyper-responsiveness and allergy in a 
population sample of 408 children and adolescents 
from Copenhagen, Denmark, was undertaken. The 
sample was studied twice 6 yr apart, using the same 
symptom questionnaire and methods for objective 
evaluation of lung function, bronchial responsiveness 
and sensitization to common aeroallergens. 
Materials and Methods 
SUBJECTS 
A sample of 983 children and adolescents living 
in the area surrounding the National University 
Hospital (Rigshospitalet) in the City of Copenhagen 
was drawn at random from the civil registration list 
in 1986; all subjects were born in the first week of 
each month with a mean age of 12 years (range 7-17 
years). In 1986 (baseline study) and 1992 (follow-up 
study), all subjects (n=983) were invited by letter to 
participate in a study concerning asthma, allergy and 
bronchial hyper-responsiveness. 
Of the 983 subjects, 527 (54%) participated in the 
baseline study and 665 (68%) participated in the 
follow-up study; 408 subjects (199 males and 209 
females) participated in both examinations. A com- 
parison of these 408 subjects to both the drop-outs 
and the newcomers has been published previously (8). 
Briefly, apart from a significantly higher number of 
current smokers among the newcomers (32% VS. 
45%) no differences were found between the groups 
with respect to anthropometric data or pulmonary 
function. The number of subjects among the drop- 
outs (n= 119) and the newcomers (n=257), respect- 
ively, with asthma (five and 27), rhinitis and/or 
eczema (14 and 67) a positive skin prick test (32 and 
104) and a positive histamine challenge test (11 and 
36) did not differ significantly from the numbers 
found among the subjects who participated in both 
examinations, suggesting that the 408 subjects were 
representative of the whole sample. Of the 199 
subjects who participated in neither of the examin- 
ations, case history was obtained by telephone or 
letter from 124 subjects, whereas no medical history 
was available from the remaining 75 (8% of the 
original sample) subjects. The proportion of sub- 
jects reporting symptoms suggesting a diagnosis of 
asthma did not differ substantially between the 
124 subjects, who answered the questionnaire only, 
and the 408 subjects, who participated in both 
examinations. 
EXCLUSION CRITERIA 
The subjects were asked to abstain from smoking 
for at least 2 h before the examination. In case they 
were taking medication for asthma/allergy, they were 
asked not to take theophylline or an anti-histamine 
for at least 24 h, astemizole for 6 weeks, or an oral 
&-agonist for 18 h, and not to use an inhaled 
bronchodilator for 6 h before the tests; they contin- 
ued with any inhaled or oral corticosteroids they 
were using. 
CASE HISTORY 
The participants and, if present, their parents were 
interviewed by one of the authors about birthweight, 
diseases (respiratory and non-respiratory), active and 
passive smoking, use of medication, known or sus- 
pected allergic disease/allergy, pets in the household, 
and use of eiderdowns and carpets in the bedroom. 
Furthermore, all participants filled in a question- 
naire about asthmatic (see below) and allergic symp- 
toms, i.e. rhinitis (sneezing, running or blocked nose 
not associated with a cold) and eczema (an itchy dry 
rash on face, arms or legs), as related to themselves, 
their siblings and their parents. 
Wheezy bronchitis was defined as a history of 
episodes of breathing difficulties with wheezing 
triggered by a respiratory tract infection before the 
age of 2 years. Disposition to allergic disease was 
recorded if either one or both of the parents had a 
history, past or present, of asthma, allergic rhinitis 
and/or atopic dermatitis. 
The questionnaire concerning respiratory symp- 
toms and the definition of asthma were adapted from 
the American Thoracic Society, Division of Lung 
Disease of the National Heart, Lung and Blood 
Institute (NHLBI) (9,lO) and Hopp et al. (11,12). 
Asthma was defined by questionnaire criteria based 
on the responses to the following questions: 
(1) Have you ever had asthma? 
(2) Does your breathing ever sound wheezy or 
whistling? 
(3) Do you have attacks of shortness of breath with 
wheezing? 
(4) Do you experience wheezing, chest tightness, 
cough, breathlessness with any of the following: at 
rest, with exertion, with emotional stress, with expo- 
sure to cold air, with chest infections or head cold? 
(5) Do you experience wheezing after exposure to: 
dust, fumes, moulds, pollen, food, pets or drugs? 
(6) Have you ever been hospitalized or observed and 
treated by a doctor for asthma? 
(7) Have you ever received medication for your 
asthma? 
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(8) What was the medication used? 
(9) Did it help? 
(10) How many episodes of wheezing have you had 
during the last year? and 
(11) Have you ever had attacks of wheezing, short- 
ness of breath or dry cough at night? 
Asthma was defined on the basis of positive 
responses to Questions 2, 3, 4 and/or 5. Current 
asthma was defined as symptoms within the 
preceding 12 months. 
Furthermore, all participants reported whether 
they were current smokers, ex-smokers or never- 
smokers, and for the first two categories they 
reported the duration of smoking. Current and 
ex-smokers also reported their daily tobacco con- 
sumption, and an estimate of their lifetime tobacco 
exposure was calculated as pack-years [current 
tobacco consumption [g day- l/20] * duration of 
smoking (yrs)]. Smoking history (daily tobacco con- 
sumption and duration of smoking) was obtained for 
both parents and included in the analysis as an 
estimate of passive tobacco exposure (for members of 
the participant’s household only). 
PULMONARY FUNCTION TESTS 
The forced expiratory volume in 1 s (FEV,) and 
forced vital capacity (FVC) were measured with a 7 1 
dry wedge spirometer (Vitalographa), which was 
calibrated weekly. Each measurement consisted of at 
least three maximal expiratory manoeuvres from 
total lung capacity to residual volume with a vari- 
ation of less than 5% in FEV,. The highest FEV, and 
FVC were used in the analyses. 
Data on pulmonary function are also expressed as 
a percentage of predicted values (% pred), using 
prediction equations based on age, sex and height 
(13,14). For subjects given a bronchodilator, values 
obtained after administration of bronchodilator are 
used in the analyses. 
SKIN PRICK TEST 
Skin prick tests were performed on the volar 
surface of the forearm, using standard dilutions 
(100.000 BU ml - ‘) of allergens in 50% glycerol 
(ALK, Hsrsholm, Denmark). The allergens used 
were birch, grass, mugwort, horse, dog, cat, house 
dust mite (Dermatophagoides pteronyssinus, in 1992 
also D. farinae) and two mould (Alternaria ividis 
and Cladosporium hevbarum). Histamine HCl, 
lOmgml-‘, m 50% glycerol was used as a positive 
reference, and a negative reference (50% glycerol) 
was also included. The reactions were read after 
15-20 min. A positive skin prick test was defined as a 
positive reaction to at least one of the allergens (15). 
The reaction to each of the allergens was regarded as 
positive if the mean wheal diameter [(dl+d2) x 41 was 
at least 3 mm (15). In case of reaction to the negative 
reference, a positive result was recorded when the 
difference between the largest diameter of the 
reaction to the allergen and to the negative reference 
exceeded 3 mm. Subjects were considered allergic if 
they had a positive skin prick test. 
SERUM IGE 
The total serum IgE levels were determined by 
paper radioimmunosorbent test (PRIST, Pharmacia, 
Sweden). The upper reference limits for total serum 
IgE were defined according to Backer et al. (16). 
Determination of total IgE levels were only per- 
formed at the examination in 1986. 
HISTAMINE CHALLENGE TEST 
Bronchial responsiveness to inhaled histamine was 
measured using the method described by Cockcroft 
et al. (17). Aerosols of the test solution were gener- 
ated by a Wright nebulizer (Aerosol Products Ltd., 
London, U.K.) operated to give an output of 
0.14mlmin’. Each aerosol was inhaled through 
the mouth by tidal breathing for 2 min. The first 
aerosol was saline (0.9%), and it was followed at 
4-min intervals by two-fold increasing concentra- 
tions of histamine (0.075 to 8.0 mg mll I; up to 
16.0 mg mll i at the follow-up examination). The 
response was measured by the FEV, 1 min after each 
inhalation. The test was terminated when a 20% or 
more decline in FEV, from the post-saline value 
occurred, or at the end of the dose schedule if such a 
decline did not occur. For all subjects having at least 
20% decline in FEV, by the end of the dose schedule, 
the concentration of histamine causing a 20% fall in 
FEV, (PC,,) was calculated by linear interpolation 
from the individual log dose-response curve as 
follows (18): 
PC,,=anti-log[logC, +(logC, - logCJ(20 - R,)/ 
where: 
0% - RJI 
C, is second last concentration of histamine (~20% 
FEV, fall), C, is last concentration of histamine 
(>20% FEV, fall), R, is % fall FEV, after C,, and R, 
is % fall FEV, after C,. 
A positive test was defined as a PC,, 
FEV, ~8.0 mg ml - ’ histamine. 
STATISTICAL METHODS 
Unless stated otherwise, the prevalence figures 
given are the cumulative prevalence rates from birth 
to the time of the examinations. Separate cross- 
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Table I Characteristics of the population sample comprising 408 subjects, aged 7-17 years at 
enrolment, examined in 1986 and 1992 
Baseline study Follow-up study 
(n=h;199) (n=F209) (n=Y99) (@,F209) 
Age (years) 
Range 
Smoking habits 
Never-smokers 
Ex-smokers 
Current smokers 
Pack-years 
FEV, (1) 
FEV, (% pred) 
Range 
FEVJFVC (%) 
Range 
12.1 (2.9) 12.5 (2.9) 18.1 (2.9) 18.5 (2.9) 
8-17 7-11 14-23 13-23 
189 188 143 125 
0 1 0 10 
10 20 
2.S5;62.0) 
74 
2.1 (1.8) 
2.6T.O) 2.4 (0.7) 4.4 (03) 3.5 (0.5) 
91 (12) 96 (12) 94 (14) 98 (11) 
57-125 68-137 53-140 68-136 
89 (6) 91 (4) 86 (7) 88 (6) 
61-99 79-99 66-98 74-98 
Standard deviations in parentheses. 
sectional analyses were performed on the data from 
the two examinations; furthermore, the data from the 
first examination were used to predict end-points, i.e. 
symptoms of asthma at the second examination. 
Variables are reported as arithmetric means and 
standard deviations. 
Changes in the proportion of subjects with symp- 
toms of asthma, positive skin prick test, and positive 
reaction to house dust mite or histamine challenge 
test were assessed by means of McNemar’s Chi- 
square test. Differences between groups in level of 
pulmonary function were analysed using Student’s 
paired or unpaired t-test, as appropriate. 
Logistic regression analysis were used to assess 
putative risk factors at the first examination in rela- 
tion to outcome at the second examination, primarily 
to the presence or absence of respiratory symptoms 
indicating asthma, and non-significant variables were 
deleted by backward elimination. A P value ~0.05 
was considered significant. 
Results 
Complete data was available for 408 subjects, 199 
males and 209 females; characteristics of the exam- 
ined subjects are displayed in Table 1. Twenty-two 
(5.4%) and 61 (15.0%) subjects fulfilled the criteria for 
a diagnosis of asthma in 1986 and 1992, respectively; 
the distribution of subjects with and without asthma 
by age is shown in Fig. 1. Two subjects with current 
asthma in 1986 reported having had no symptoms of 
asthma within the 12 months prior to the follow-up 
examination, whereas 41 subjects without respiratory 
symptoms in 1986 had current symptoms of asthma 
in 1992. The prevalence of current cigarette smokers 
at the follow-up examination was high, 28% 
males and 35% females, with an average number of 
pack-years being 2.8 in males and 2.1 in females. 
The 12-month period prevalence of asthma 
increased significantly from the first to the second 
examination in both males and females, whereas the 
proportion of subjects with a positive histamine 
challenge test declined, statistically significant in 
males only. Furthermore, a significant increase in the 
number of subjects with a positive skin prick test was 
observed in both sexes, primarily due to an increase 
in the number of subjects with a positive reaction to 
house dust mites (Table 2 and Fig. 2). 
A positive histamine challenge test, a positive skin 
reaction to house dust mite allergen, a history of 
wheezy bronchitis in early childhood and symptoms 
of asthma at the first examination were more preva- 
lent among subjects reporting symptoms of asthma at 
the second examination than in subjects without 
respiratory symptoms. 
Confining the analysis to subjects without symp- 
toms of asthma at the first examination showed that 
asymptomatic hyper-responsiveness to inhaled hista- 
mine, positive skin reaction to HDM, a history of 
wheezy bronchitis before the age of 2 years and a 
history of rhinitis and/or eczema at first examination 
were all associated with an increased risk for devel- 
opment of symptomatic asthma at some time 
between the two examinations (Table 3). No signifi- 
cant relationship could be demonstrated between 
smoking (passive or active) and the risk for develop- 
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Fig, I Distribution of subjects with and without current asthma by age in a population sample (n=408) examined in (a) 
1986 and (b) 1992. Solid bars, non-asthmatics; hatched bars, asthmatics. 
ment of symptomatic asthma, which may be due to 
the relatively low number of subjects with asthma in 
the sample. 
Discussion 
The observed 12-month period prevalence of 
symptomatic asthma in the population sample of 
children and adolescents increased substantially from 
1986 to 1992, which is in keeping with findings in two 
studies published recently (43). Furthermore, the 
same methods were used at the two examinations 
and, as published previously (8) and mentioned 
briefly, no indication of drop-out bias was found; 
therefore, the present findings may suggest an 
Table 2 Prevalences of asthma, allergy and bronchial 
hyper-responsivess in the population sample comprising 408 
subjects examined in 1986 (Baseline study) and in 1992 
(Follow-up study) 
Baseline study Follow-up study 
M 
(n=199) (ZO9) (n 299) (R=:09) 
Asthma, 12 (%) 12 (6)* 10 (5)* 30 (15)* 31 (15)* 
Rhinitis, IZ (%) 27 (14)f 31 (15)t 46 (23)T 44 (21)t 
Eczema, n (%) 12 (6) 15 mt 18 (9) 28 UN 
Pos SPT, n (%) 55 (28)* 51 (24)* 96 (48)* 82 (39)* 
HDM IZ (%) pos, 31 (16)* 24 (12)* 60 (30)* 47 (23)* 
BHR hist, IZ (%) 44 (22)* 36 (17) 10 (5)* 14 (7) 
SPT, skin prick test; HDM, house dust mite; BHR hist, 
bronchial hyper-responsiveness to inhaled histamine. 
*P<O.OOl, tP<O.Ol (Baseline study vs. Follow-up study in 
males and females, respectively). 
increase in prevalence of current asthma. However, 
other explanations for this trend should be consid- 
ered. The increased medical concern and publicity 
surrounding asthma in recent years may have led to 
an increase in the recognition of various respiratory 
symptoms as having asthma as the underlying cause. 
However, although the increase may partly reflect 
age-dependent variation, the strong relationship 
between asthma, house dust mite allergy and bron- 
chial hyper-responsiveness suggests a real increase in 
12-month period prevalence, possibly primarily due 
to changes in environmental factors. 
Peat et al. (5) have reported an increase in the 
prevalence of bronchial hyper-responsiveness in a 
serial cross-sectional study of children aged S-10 
years from two areas of Australia, but the prevalence 
of both diagnosed asthma and use of asthma medi- 
cation was much higher than the prevalence of cur- 
rent wheeze at the second part of their survey. A 
serial cross-sectional study of adults (19) showed an 
unchanged prevalence of hyper-responsiveness and 
current asthma, although the reporting of respiratory 
symptoms increased. These findings strongly suggest 
an increased awareness of asthma among both 
doctors and lay people, although the finding of an 
increased prevalence of BHR suggests an increase 
in prevalence of airway abnormalities among 
Australian children. The proportion of subjects 
with BHR in the present study declined from 1986 to 
1992, but asymptomatic BHR found in 1986 was a 
strong predictor for subsequent development of 
symptomatic asthma. It has been shown pre- 
viously that the degree of non-specific bronchial 
responsiveness may decrease in children and adoles- 
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, 
n=41 a=23 rt=61 
(10%) (6%) (15%) 
n = 283 (69%) b 
I 
n = 55 (14%) n = 353 
n=44 
(11%) 11=5;; n(z 0 0 IL = 290 (71%) b 
Fig. 2 Proportion of subjects with asthma, non-specific bronchial hyper-responsiveness (BHR), a positive skin prick test 
(SPT) and a positive skin reaction to house dust mite (HDM), respectively, in a population sample of children and 
adolescents, aged 7-17 years at enrolment, examined in (a) 1986 and (b), in 1992. Numbers given on the right side of the 
vertical line are the proportion of subjects with no symptoms/negative tests at both examinations. Numbers given on the left 
side of the vertical line are for a: symptoms/positive test in 1986; and for b (from left): symptoms/positive test in both 1986 
and 1992, no symptoms/negative test in 1986 but symptoms/positive test in 1992 an symptoms/positive test in 1986 but no 
symptoms/negative test in 1992. 
cents with increasing age (20,21), possibly due to an 
absolute increase in airway calibre (22), as a strong 
relationship between airway calibre, expressed as 
prechallenge FEV, , and histamine responsiveness, 
Table 3 Risk factors [Odds ratio (OR) and 95% confidence 
interval (CI)] for the development of asthma in a population 
sample of children and adolescents, aged 7-17 years at 
enrolment, examined in 1986 and in 1992* 
OR (95% CI) P value 
Bronchial hyper-responsiveness 3.8 (2.5-5.1) 0.0002 
House dust mite allergy 2.6 (1.9-3.3) 0.005 
Wheezy bronchitis? 3.8 (2.4-5.2) 0,006 
Rhinitis and/or eczema$ 2.8 (1.7-3.9) 0,007 
*Subjects reporting symptoms of asthma at the examination 
in 1986 (n=22) were excluded from the analysis. 
?A history of wheezy bronchitis before the age of 2 years. 
$A history of rhinitis and/or eczema, for definitions see text. 
No significant relationship could be demonstrated between 
gender, age, birth weight, breast-feeding, month of birth, 
passive or active smoking, disposition to allergic disease 
(a history of asthma, rhinitis and/or eczema in either one or 
both of the parents), level of FEV, % pred, total serum IgE 
and other positive skin reactions (pollen, animals and 
moulds), and risk for development of asthma. 
expressed as the dose-response slope, has been 
reported previously in both children (23) and adults 
(24) with asthma. The differences between cross- 
sectional observations and the findings in this 
longitudinal study may, therefore, reflect the 
natural history of non-specific bronchial hyper- 
responsiveness in a population sample with an 
unchanged proportion of subjects with airway 
abnormalities. 
The increase in the number of subjects with house 
dust mite allergy in combination with the observed 
relationship between house dust mite allergy and 
subsequent risk for development of asthma suggest 
that changes in environmental factors might be 
involved, directly or indirectly, in triggering asthma, 
although a causal relationship between sensitization 
to house dust mite and development of asthma has 
yet to be ascertained. The overall increase in the 
prevalence of subjects with allergy, defined as a 
positive skin prick test, and the increasing prevalence 
of rhinitis and eczema in both males and females 
(Table 2) supports this assumption. 
Airway hyper-responsiveness to inhaled agents 
such as histamine and metacholine is found in most 
current asthmatics, but its presence alone does not 
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verify the diagnosis (25,26). In a small group of 
subjects, Hopp et al. (27) have demonstrated that 
enhanced airway responsiveness usually precedes the 
development of asthma. This finding is confirmed in 
the present study, probably because in contrast to 
other epidemiological studies, the presence of a posi- 
tive histamine challenge test was not included in the 
present definition of asthma, since many subjects with 
BHR most likely never develop symptomatic asthma. 
However, the authors acknowledge that their 
questionnaire-based criteria of asthma are arbitrary, 
and that the use of other definitions might change the 
la-month period prevalence of asthma and the rela- 
tionship between hyper-responsivness and risk for 
subsequent development of symptomatic asthma. 
However, it would most likely not have changed the 
association between bronchial hyper-responsiveness, 
house dust mite allergy and development of asthma. 
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